Adalimumab alone and in combination with disease‐modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

OBJECTIVE: To evaluate the safety and effectiveness of adalimumab alone or in combination with standard disease‐modifying antirheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis (RA). METHODS: Patients with active RA despite treatment with DMARDs or prior treatment with a tumour necro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burmester, Gerd R, Mariette, Xavier, Montecucco, Carlomaurizio, Monteagudo‐Sáez, Indalecio, Malaise, Michel, Tzioufas, Athanasios G, Bijlsma, Johannes W J, Unnebrink, Kristina, Kary, Sonja, Kupper, Hartmut
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954645/
https://ncbi.nlm.nih.gov/pubmed/17329305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.066761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados